MedTrace Logo

2D:4D Finger Ratio and Breast Cancer in Women

NCT07436169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2026-02-27

No results posted yet for this study

Summary

This prospective study aims to evaluate the 2D:4D finger ratio in women diagnosed with breast cancer compared to healthy controls and to examine its potential association with tumor markers, including carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA 15-3).

A total of 132 women are included in the study, comprising 79 patients with breast cancer and 53 healthy controls. Participants are recruited from a breast clinic setting. Finger lengths are measured to calculate 2D:4D ratios, and serum CEA and CA 15-3 levels are recorded. Statistical analyses are performed to assess correlations between finger morphometry and tumor marker levels.

The study seeks to explore whether finger length patterns and 2D:4D ratios are associated with breast cancer status and selected tumor markers, and to evaluate their potential relevance as non-invasive indicators related to hormonal exposure history.

Conditions

Sponsors & Collaborators

  • Malatya Turgut Ozal University

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-07-02
Completion
2025-08-07

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07436169 on ClinicalTrials.gov